ChemicalBook > Product Catalog >Pharmaceutical intermediates >Bulk Drug Intermediates >Vonoprazan fumarate

Vonoprazan fumarate

Vonoprazan fumarate Structure
CAS No.
1260141-27-2
Chemical Name:
Vonoprazan fumarate
Synonyms
Vonoprazan FuMarate;Vonaprazan;5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine 2-butenedioate (Vonoprazan);Vonaprazan(TAK-438);Vonoprazon Fumarate;Vonoprazan fumarate(TAK-438);vonoprazan(tak-438)1260141-27-2;5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine 2-butenedioate;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine,(E)-4-oxopent-2-enoic acid;AK-438
CBNumber:
CB32628441
Molecular Formula:
C21H20FN3O6S
Molecular Weight:
461.4634032
MOL File:
1260141-27-2.mol
Modify Date:
2024/6/7 16:47:56

Vonoprazan fumarate Properties

storage temp. Store at -20°C
solubility insoluble in H2O; insoluble in EtOH; ≥18.9 mg/mL in DMSO
form solid
InChIKey ROGSHYHKHPCCJW-WLHGVMLRSA-N
SMILES N1(S(C2=CC=CN=C2)(=O)=O)C(C2=CC=CC=C2F)=CC(CNC)=C1.C(O)(=O)/C=C/C(O)=O

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H315-H319-H335
Precautionary statements  P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P321-P362+P364-P332+P313-P337+P313-P403+P233-P405-P501
NFPA 704
0
2 0

Vonoprazan fumarate Chemical Properties,Uses,Production

Description

Vonoprazan fumarate (Takecab®), discovered and developed by Takeda and Otsuka, was approved by the PMDA of Japan in December 2014, and is indicated for the treatment of gastric ulcer, duodenal ulcer and reflux esophagitis. Vonoprazan fumarate has a novel mechanism of action called potassium-competitive acid blockers, which competitively inhibit the binding of potassium ions to H+, K+-ATPase (also known as the proton pump) in the final step of gastric acid secretion in gastric parietal cells. Vonoprazan does not inhibit Na+, K+-ATPase activity even at concentrations 500 times higher than that of their IC50 values against gastric H+, K+-ATPase activity. Furthermore, the drug is unaffected by the gastric secretory state, unlike PPIs.

Uses

Vonoprazan Fumarate is a novel potassium-?competitive acid blocker for the treatment of acid-?related diseases.

Application

Vonoprazan fumarate is an oral, newly synthesised potassium-competitive acid blocker (P-CAB) with antisecretory activity. It is also a proton pump inhibitor (PPI) reversibly inhibiting H+/K+, ATPase. It is mainly used in the treatment of acid-related diseases such as GERD and peptic ulcer disease.

Synthesis

Commercially available 2-fluoroacetophenone (283) was brominated to yield a-bromo-acetophenone derivative 284. This compound was treated with ethyl 2-cyanoacetate (285) under basic conditions to provide ketoester 286 in essentially quantitative yield. Next, intramolecular condensation of 286 upon treatment of 4 M HCl furnished the tri-substituted pyrrole 287 in 53% yield. Reduction of the chloride under hydrogenolytic conditions facilitated arrival at pyrrole 288, albeit in just 18% yield. Subsequent diisobutylaluminium hydride (DIBAL) reduction, followed by the oxidation with tetrapropylammonium perruthenate (TPAP) and 4-methylmorpholine N-oxide (NMMO) afforded the corresponding aldehyde 290 in 60% yield across the 2 steps. Next, N-pyrrole substitution with pyridine- 3-sulfonyl chloride 291 gave rise to N-sulfonylpyrrole 292 in 82% yield. Reductive amination of 292 afforded amine 293, which was treated with fumaric acid (294) via co-crystallization to provide vonoprazan fumarate (XXXVI) in 74% for the two steps.

Synthesis_1260141-27-2

Vonoprazan fumarate Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 472)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Dr. Reddy's Laboratories Ltd +91-4049002900 +91-4049002900 Hyderabad, India 165 58 Inquiry
SHOBHA LIFE SCIENCES PRIVATE LIMITED +919121212469 Hyderabad, India 31 58 Inquiry
Veer Pharmachem +91-02645661117 +91-9879471589 Gujarat, India 39 58 Inquiry
Metrochem API Private Limited +91-4069069999 +91-4069069999 Telangana, India 78 58 Inquiry
Centaur Pharmaceuticals Pvt Ltd +912266499100 Mumbai, India 33 58 Inquiry
Anlon Healthcare Pvt Ltd +91-2812562538 +91-7069690081 Gujarat, India 54 58 Inquiry
Mehta API Pvt. Ltd. +91-9920552082 +91-9920552082 Maharashtra, India 33 58 Inquiry
Morepen Laboratories Ltd +91-7017029282 +91-9818305894 Haryana, India 34 58 Inquiry
Ami Lifesciences Pvt Ltd +91-9426998100 +91-9426998100 Gujarat, India 62 58 Inquiry
Maithri Drugs Pvt Ltd +91-9059204566 +91-9848881740 Telangana, India 64 58 Inquiry
1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine AK-438 vonoprazan(tak-438) fuMarate vonoprazan 1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-, 2-butenedioate (1:1) 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine 2-butenedioate TAK 438 vonaprazan(TK-438) TAK-438 Vonoprazan fumarate VONOPRAZAN FUMARATE (TAK-438);TAK-438 TAK 438,Vonoprazan TAK-438 1-(5-(2-FLUOROPHENYL)-1-(PYRIDIN-4-YLSULFONYL)-1H-PYRROL-3-YL)-N-METHYLMETHANAMINE 4-Aminopyrazolo[3 vomoprazan fumarate Vonoprazan Fumarate-D3Q: What is Vonoprazan Fumarate-D3 Q: What is the CAS Number of Vonoprazan Fumarate-D3 Vonoprazan Vonoprazan onoprazan Vonoprazan fumarate Vonorasen fumarate Vonoprazan fumarate API Vonoprazan Fumarate DISCONTINUED PLEASE SEE V767013 TAK-438 ISO 9001:2015 REACH TAK-438 USP/EP/BP TAK-438,1260141-27-2 Fluorine Prazan 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine 2-butenedioate (Vonoprazan fumarate) Wonarazan Fumarate CS-597 TAK 438; TAK438 Vonoprazan-025-Salt2 Vonolazan Fumarate API Vonaprazan 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine 2-butenedioate (Vonoprazan) Vonaprazan(TAK-438) Vonoprazan fumarate(TAK-438) vonoprazan(tak-438)1260141-27-2 1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine,(E)-4-oxopent-2-enoic acid Vonoprazan FuMarate 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine 2-butenedioate Vonoprazon Fumarate Vorolazan fumarate Fumarate vonolasan Vonorazon 1260141-27-2 88168-00-2 260141-27-2 C17H16FN3O2SC4H4O4 Vonoprazan Inhibitors API 1260141-27-2